XTalks

MARCH 17, 2025

Looking ahead, the company plans to expand into North American and European markets by preparing localized production and regulatory filings, and it aims to initiate clinical research for its A+LCGuard lung cancer screening kit by mid-2025 underscoring its commitment to rapid, affordable and reliable diagnostics.

Production 71

Production Manufacturing DNA Genetics 71

Worldwide Clinical Trials

JUNE 21, 2024

The 2024 ASCO Annual Meeting from the American Society of Clinical Oncology is a fantastic platform for clinical researchers to discuss the latest advancements and challenges in oncology research. ADCs are continually evolving, bringing forward new targets across various cancer types, including rare and orphan cancers.

Antibody 162

Antibody Clinical Trials Clinical Trials In-Vitro 162

Advarra

JUNE 12, 2023

Gene therapy research is exciting and full of promise, but because of the risks involved, it’s also highly regulated, requiring an institutional biosafety committee (IBC) to provide additional oversight and risk assessment. The IBC also reviews to confirm a comprehensive risk mitigation plan is in place prior to starting the research.

Genetic Engineering 98

Genetic Engineering Gene Therapy Genetics Engineer 98

Advarra

JUNE 13, 2024

Recombinant DNA technologies and genetically modified biological agents are being adapted for a wide scope of therapeutic applications, and their use is becoming increasingly common in clinical trials. How can I protect myself from exposure? What should I do if I’m exposed?

Genetic Engineering 52

Genetic Engineering Clinical Trials Clinical Trials Engineer 52

pharmaphorum

AUGUST 5, 2021

Critical cellular processes including DNA replication and translation cannot occur without functional-specific proteins. A recent clinical research paper highlights the importance of targeting of PPIs in stem cells of cancer. What does this mean for clinical research? Charlotte Di Salvo.

Protein 126

Protein Gene Bioassay DNA 126

Pharmaceutical Technology

FEBRUARY 20, 2023

We look forward to deepening our collaboration in next decades and contributing more to state-of-the-art clinical trials for efficient medicine to patients’ benefits throughout the world”, says XU Yi, CEO Teddy Clinical Research Laboratory. SZ) and Tigermed (300347.SZ

Research 130

Research Clinical Trials Clinical Trials Clinical Research 130

XTalks

FEBRUARY 4, 2021

Bernard, executive vice president for research and chief research officer at Vanderbilt University Medical Center, shared his experience in helping set up a DNA and clinical data resource called BioVU. Dr. Bernard’s clinical research interests are in the areas of sepsis and acute respiratory distress syndrome (ARDS).

Research 98

Research Biobanking Drugs Genomics 98

pharmaphorum

MARCH 31, 2022

UK startup Sano Genetics has raised $11 million in first-round financing to develop its go-between service, which aims to overcome one of the big challenges in clinical research by connecting patients with trial sponsors.

Trials 52

Trials Genetics DNA Clinical Trials 52

WCG Clinical

AUGUST 27, 2024

The NIH Guidelines also stipulate that at least two members of each IBC come from the surrounding community and be unaffiliated with the institution where the research is occurring apart from their membership on the IBC. Many of those original concerns of the 1970s and 1980s surrounding genetic engineering have lessened over time.

Genetic Engineering 52

Genetic Engineering Engineer Compliance Genetics 52

XTalks

DECEMBER 28, 2023

Utilizing BillionToOne’s unique molecular counting technology, Quantitative Counting Templates (QCTs), the test employs next-generation sequencing (NGS) to detect genetic variants linked to the relevant fetal antigens. This test can be performed as early as the tenth week of pregnancy.

Trials 97

Trials Clinical Trials Clinical Trials Antibody 97

WCG Clinical

JUNE 24, 2024

Genetic manipulation has an interesting history of self-regulation in the United States (US). In 1953, Watson and Crick formulated the current description of DNA as a double helix 1 and soon thereafter experiments with restriction endonucleases gave scientists the ability to modify and manipulate DNA 2. References Pray, L.

DNA 52

DNA Regulation Scientist Research 52

pharmaphorum

DECEMBER 20, 2022

Another focus is ensuring that we remain world-leading in our current research and clinical programmes by investing in infrastructure, the newest technologies and by continuing to develop and recruit the most outstanding scientists and clinician-scientists. A fresh approach.

Scientist 98

Scientist Research Genetics Drugs 98

Pharmaceutical Technology

FEBRUARY 20, 2023

This level of homogeneity within the clinical trial population may prevent the identification of variable therapy responses within population subgroups. Yet, multiple diseases are endemic to Africa as a result of poverty and climate.

Research 130

Research Clinical Trials Clinical Trials Trials 130

Roots Analysis

NOVEMBER 5, 2023

By analyzing the genetic makeup of the tumor, healthcare providers can assess whether a treatment is effectively targeting the cancer, allowing for timely adjustments if necessary. Tumor Heterogeneity: Cancer is known for its genetic heterogeneity, meaning different regions of a tumor can have distinct genetic profiles.

Marketing 40

Marketing Genetics DNA Research 40

The Pharma Data

JUNE 24, 2021

The study will evaluate the efficacy and safety of talazoparib, an oral poly (ADP-ribose) polymerase (PARP) inhibitor, in combination with enzalutamide, an androgen receptor inhibitor, compared with placebo plus enzalutamide in men with DNA damage response (DDR)-deficient metastatic castration-sensitive prostate cancer (mCSPC).

DNA 52

DNA Clinical Trials Clinical Trials Trials 52

The Pharma Data

OCTOBER 18, 2020

(NASDAQ:CDXC) today highlighted a new study published in The European Molecular Biology Organization Journal looking at the effect of nicotinamide riboside (NR) on maintaining telomeres, the protective regions at the end of DNA strands. Telomeres are “caps” at the end of chromosomes that protect DNA from getting worn away as cells replicate.

DNA 52

DNA Scientist Genetic Disease Research 52

XTalks

NOVEMBER 7, 2022

Liquid biopsy tests in oncology involve isolating entities such as circulating tumor cells (CTC), circulating tumor DNA (ctDNA) and tumor-derived exosomes. The cfDNA that originates from tumors is called circulating tumor DNA (ctDNA). These tumor-derived entities are used to derive genomic and proteomic data.

Clinical Trials 98

Clinical Trials Clinical Trials Trials FDA Approval 98

Advarra

AUGUST 10, 2023

However, recent advancements in the clinical use of recombinant DNA (rDNA) technology creates opportunities for changing this calculation and addressing a great, unmet medical need. “I The project should also help clinical research sponsors take advantage of various FDA pathways for accelerated review and approval.

Gene Therapy 52

Gene Therapy Development Gene Drugs 52

Cloudbyz

JULY 31, 2024

This revolution is enabling the growth of innovative biomarker-based precision medicine and cell and gene therapy, transforming both clinical research and post-market care. For instance, in oncology, patients with specific genetic mutations (e.g.,

Gene Therapy 52

Gene Therapy Gene Medicine In-Vitro 52

Cloudbyz

NOVEMBER 3, 2021

Biosamples and biomarkers are the core basis for much of the work done in the clinical research industry and proficient Human Biosample Management (HBSM) is necessary to procure reliable biosamples. For a rapidly growing subfield of clinical research such as HBSM, the long-term future can be very difficult to predict.

Biobanking 52

Biobanking Clinical Research Research Contamination 52

Pharmaceutical Technology

MAY 9, 2023

The shared expertise and resources enables Cerba Research to broaden its services within cell and gene therapy, infectious disease and oncology and access new markets in North America, Asia and Africa, the sites of some of the most exciting growth in clinical trials. of the global trial landscape.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Big Data 130

The Pharma Data

DECEMBER 20, 2020

eTrueNorth is actively recruiting COVID-19-positive patients about potential participation in the NIH’s ACTIV-2 clinical research trial. Alagille syndrome is a rare, multisystem genetic disorder affecting the liver, heart, skeleton, eyes, CNS, kidneys and facial features.

Trials 52

Trials Gene Therapy Vaccination Vaccine 52

XTalks

OCTOBER 1, 2020

Lin has made several transitions throughout her career, from being a clinician at an academic center, to academic research, to heading business development in industry. Working on finding therapies for genetic diseases at NeuBase, Dr. Sooter says, “Everyday, we get up and that’s our goal and it really drives everyone.

Scientist 52

Scientist In-Vitro Research Life Science 52

XTalks

SEPTEMBER 14, 2020

CanSino Biologics is developing a vaccine that involves snipping a bit of the virus’ genetic code off and coupling it with a harmless virus to provoke a SARS-CoV-2 immune response. Several laboratories have already shown that they can detect genetic material from the virus in wastewater.

Vaccine 92

Vaccine Vaccination Antibody Life Science 92